COAG Trial: No Advantage Seen with Genetic-Based Warfarin Dosing

Article Figures & Data

Figures

  • Figure 1.

    Intervention Period (Days 1 to 5)

    Reproduced from Kimmel SE et al. Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. Am Heart J 2013;166(3)435–441. With permission from Elsevier.